Scientists search for metabolic clues in breast tumors
NCT ID NCT03367208
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at small molecules called metabolites in breast cancer tumors to find patterns that could help understand the disease better. Researchers analyzed 52 tumor samples and some blood samples from patients who had surgery. The goal was to identify possible biomarkers for diagnosis or treatment, not to test a new therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better understanding of breast cancer biology and new biomarkers for diagnosis or treatment targets.
- What could go wrong
- This is a small, retrospective study with only 52 samples, so findings may not apply to all patients or lead to practical tests.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Antoine Lacassagne
Nice, Cedex 2, 06189, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?